2019 RIS Research Grants for UMN
Rein in Sarcoma proudly announces a $150,000 research grant approved by the Rein in Sarcoma Board in January, 2019. This grant will fund the following three exciting University of Minnesota Masonic Cancer Center projects: “MYOG Promoter-Controlled Oncolytic Adenovirus to Treat PAX3-FOXO1-Positive Rhabdomyosarcoma” | $50,000 Principle Investigator: Masato Yamamoto, MD, PhD Co-Investigator: H Yoshida, MD, PhD…